ÂÜÀòÂÒÂ×

Senior Vice President of Corporate Development, Todd Milne, PhD, brings more than 20 years of experience in the biopharma industry. Prior to Cyclerion, Todd was a co-founder of Ironwood Pharmaceuticals where he held a number of scientific program and functional leadership roles, including leading sGC stimulator discovery and early development efforts at Ironwood. He is also one of the inventors of LINZESS®, a market-leading treatment for irritable bowel syndrome with constipation and chronic idiopathic constipation. Prior to founding Ironwood, Todd was a postdoctoral research fellow at Whitehead Institute for Biomedical Research. Todd earned a B.S. in molecular biophysics and biochemistry from Yale University and a Ph.D. in microbiology and molecular genetics from Harvard University.